UniProt ID | AAKB1_HUMAN | |
---|---|---|
UniProt AC | Q9Y478 | |
Protein Name | 5'-AMP-activated protein kinase subunit beta-1 | |
Gene Name | PRKAB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 270 | |
Subcellular Localization | ||
Protein Description | Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Beta non-catalytic subunit acts as a scaffold on which the AMPK complex assembles, via its C-terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1, PRKAG2 or PRKAG3).. | |
Protein Sequence | MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSEEIKAPEKEEFLAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNWSKLPLTRSHNNFVAILDLPEGEHQYKFFVDGQWTHDPSEPIVTSQLGTVNNIIQVKKTDFEVFDALMVDSQKCSDVSELSSSPPGPYHQEPYVCKPEERFRAPPILPPHLLQVILNKDTGISCDPALLPEPNHVMLNHLYALSIKDGVMVLSATHRYKKKYVTTLLYKPI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGNTSSERA ------CCCCHHHHH | 46.23 | 21680840 | |
2 | N-myristoyl glycine | ------MGNTSSERA ------CCCCHHHHH | 46.23 | - | |
4 | Phosphorylation | ----MGNTSSERAAL ----CCCCHHHHHHH | 28.09 | 18088087 | |
5 | Phosphorylation | ---MGNTSSERAALE ---CCCCHHHHHHHH | 33.91 | 18088087 | |
6 | Phosphorylation | --MGNTSSERAALER --CCCCHHHHHHHHH | 29.12 | 18088087 | |
19 | Phosphorylation | ERHGGHKTPRRDSSG HHCCCCCCCCCCCCC | 19.16 | 17192257 | |
24 | Phosphorylation | HKTPRRDSSGGTKDG CCCCCCCCCCCCCCC | 29.13 | 19376078 | |
25 | Phosphorylation | KTPRRDSSGGTKDGD CCCCCCCCCCCCCCC | 45.60 | 28176443 | |
28 | Phosphorylation | RRDSSGGTKDGDRPK CCCCCCCCCCCCCCC | 29.50 | 28176443 | |
35 | Ubiquitination | TKDGDRPKILMDSPE CCCCCCCCCCCCCHH | 49.74 | - | |
40 | Phosphorylation | RPKILMDSPEDADLF CCCCCCCCHHHHHCC | 19.07 | 30266825 | |
49 | Phosphorylation | EDADLFHSEEIKAPE HHHHCCCCCCCCCCC | 29.59 | 54886891 | |
53 | Ubiquitination | LFHSEEIKAPEKEEF CCCCCCCCCCCHHHH | 62.26 | - | |
57 | Ubiquitination | EEIKAPEKEEFLAWQ CCCCCCCHHHHHHHC | 62.58 | 21890473 | |
72 | Ubiquitination | HDLEVNDKAPAQARP CCCEECCCCCCCCCC | 51.57 | - | |
80 | Phosphorylation | APAQARPTVFRWTGG CCCCCCCEEEEECCC | 27.07 | 19376078 | |
89 | Ubiquitination | FRWTGGGKEVYLSGS EEECCCCCEEEEECC | 47.48 | - | |
92 | Phosphorylation | TGGGKEVYLSGSFNN CCCCCEEEEECCCCC | 9.02 | 30850111 | |
94 | Phosphorylation | GGKEVYLSGSFNNWS CCCEEEEECCCCCCC | 18.07 | 26657352 | |
96 | Phosphorylation | KEVYLSGSFNNWSKL CEEEEECCCCCCCCC | 22.79 | 25159151 | |
101 | Phosphorylation | SGSFNNWSKLPLTRS ECCCCCCCCCCCCCC | 26.83 | 26657352 | |
102 | Ubiquitination | GSFNNWSKLPLTRSH CCCCCCCCCCCCCCC | 45.82 | - | |
106 | Phosphorylation | NWSKLPLTRSHNNFV CCCCCCCCCCCCCEE | 28.34 | 25159151 | |
108 | Phosphorylation | SKLPLTRSHNNFVAI CCCCCCCCCCCEEEE | 25.90 | 25159151 | |
125 | Phosphorylation | LPEGEHQYKFFVDGQ CCCCCCEEEEEECCE | 16.21 | 23927012 | |
138 | Phosphorylation | GQWTHDPSEPIVTSQ CEECCCCCCCEEEEE | 63.16 | 113334293 | |
144 | Phosphorylation | PSEPIVTSQLGTVNN CCCCEEEEECCCCCC | 16.71 | 46163111 | |
148 | Phosphorylation | IVTSQLGTVNNIIQV EEEEECCCCCCEEEE | 28.75 | 26657352 | |
157 | Ubiquitination | NNIIQVKKTDFEVFD CCEEEEECCCHHHCC | 55.24 | - | |
158 | Phosphorylation | NIIQVKKTDFEVFDA CEEEEECCCHHHCCC | 39.96 | 15423663 | |
170 | Phosphorylation | FDALMVDSQKCSDVS CCCEEECCCCCCCHH | 21.82 | 26074081 | |
174 | Phosphorylation | MVDSQKCSDVSELSS EECCCCCCCHHHHCC | 48.35 | 23927012 | |
177 | Phosphorylation | SQKCSDVSELSSSPP CCCCCCHHHHCCCCC | 37.50 | 22167270 | |
180 | Phosphorylation | CSDVSELSSSPPGPY CCCHHHHCCCCCCCC | 25.39 | 22167270 | |
181 | Phosphorylation | SDVSELSSSPPGPYH CCHHHHCCCCCCCCC | 60.53 | 22167270 | |
182 | Phosphorylation | DVSELSSSPPGPYHQ CHHHHCCCCCCCCCC | 31.57 | 22167270 | |
187 | Phosphorylation | SSSPPGPYHQEPYVC CCCCCCCCCCCCCCC | 23.27 | 22167270 | |
192 | Phosphorylation | GPYHQEPYVCKPEER CCCCCCCCCCCHHHH | 20.09 | 22167270 | |
195 | Ubiquitination | HQEPYVCKPEERFRA CCCCCCCCHHHHCCC | 45.48 | - | |
252 | Phosphorylation | KDGVMVLSATHRYKK CCCEEEEEECCCCCC | 21.51 | 18691976 | |
254 | Phosphorylation | GVMVLSATHRYKKKY CEEEEEECCCCCCCE | 11.96 | 20071362 | |
261 | Phosphorylation | THRYKKKYVTTLLYK CCCCCCCEEEEEEEC | 16.35 | 28152594 | |
263 | Phosphorylation | RYKKKYVTTLLYKPI CCCCCEEEEEEECCC | 14.50 | 26074081 | |
264 | Phosphorylation | YKKKYVTTLLYKPI- CCCCEEEEEEECCC- | 12.53 | 26074081 | |
267 | Phosphorylation | KYVTTLLYKPI---- CEEEEEEECCC---- | 20.17 | 26074081 | |
268 | Ubiquitination | YVTTLLYKPI----- EEEEEEECCC----- | 35.88 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
24 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
24 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
80 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
108 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
148 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
158 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
174 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
177 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AAKB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AAKB1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96 AND SER-108, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-24; SER-25;SER-40; SER-96; SER-101; SER-108; THR-148; SER-174; SER-177; SER-180;SER-181 AND SER-252, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-40 AND SER-108,AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-4; SER-5; SER-6 ANDSER-108, AND MASS SPECTROMETRY. |